Current differentiation protocols to generate stem cell-derived β (SC-β) cells yield a cell product able to secrete insulin in response to increasing concentrations of glucose and reverse diabetes upon transplantation in mice (104). The gene discussed is INS; the disease is diabetes mellitus.